Skip to main content
editorial
. 2019 Jul 24;11(8):1041. doi: 10.3390/cancers11081041

Figure 1.

Figure 1

Strategies for cancer vaccine development. Strategies presented in this special issue on Cancer Vaccines: Research and Applications. CD, cluster of differentiation; HER1/neu, Human Epidermal Growth Factor Receptor 2; IDO, Indoleamine-2,3-dioxygenase; IGF1R, insulin-like growth factor receptor-1; MDSCS, Myeloid-derived suppressor cells; MUC1, Mucin 1; NK, natural killer; PD-1, programmed death-1; PDL-1, program death ligand 1; Sp17, cancer testis sperm protein 17.